Diagnostics

PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion

PureHealth booked a 53% y-o-y increase in revenue to AED 12.5 billion in H1 2024 following solid growth across its…

4 months ago

New Funding Announced for Revolutionary Disease Detection Technology

Noze is the first-ever Canadian company to receive investment funding from the Bill & Melinda Gates Foundation.  MONTREAL, July 30,…

4 months ago

Next Presentation in Record-Breaking Sleep Apnea Webinar Series Announced

Live presentations by leading sleep researchers available globally to front-line clinicians MURFREESBORO, Tenn., July 30, 2024 /PRNewswire/ -- SleepWorld Magazine…

4 months ago

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive…

4 months ago

VitalHub Corp. to Acquire MedCurrent Corporation

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to…

4 months ago

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brainThese tools…

4 months ago

Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform

BOULDER, Colo., July 30, 2024 (GLOBE NEWSWIRE) -- Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development…

4 months ago

AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics

CHICAGO, July 30, 2024 /PRNewswire/ -- AliveDx, a global in vitro diagnostics company that aims to transform patient care, today…

4 months ago

AngioDynamics to Participate in Upcoming Investor Conferences

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

4 months ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2024

– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded…

4 months ago